VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,686,000 | -61.9% | 105,920 | -65.7% | 0.07% | -58.9% |
Q3 2017 | $4,420,000 | +139.6% | 308,500 | +189.1% | 0.18% | +125.0% |
Q2 2017 | $1,845,000 | -47.4% | 106,704 | -66.4% | 0.08% | -47.4% |
Q1 2017 | $3,506,000 | -3.2% | 317,899 | +27.4% | 0.15% | -29.6% |
Q4 2016 | $3,621,000 | +4.8% | 249,435 | +77.3% | 0.22% | -7.7% |
Q3 2016 | $3,454,000 | -55.5% | 140,719 | -63.5% | 0.23% | -54.9% |
Q2 2016 | $7,769,000 | +17.7% | 385,788 | +53.7% | 0.52% | -1.3% |
Q1 2016 | $6,600,000 | -67.3% | 250,955 | +26.2% | 0.53% | -66.8% |
Q4 2015 | $20,207,000 | +523.7% | 198,799 | +994.2% | 1.58% | +564.7% |
Q3 2015 | $3,240,000 | +64.8% | 18,168 | +105.3% | 0.24% | +44.2% |
Q2 2015 | $1,966,000 | +159.0% | 8,851 | +131.4% | 0.16% | +87.5% |
Q1 2015 | $759,000 | -66.0% | 3,825 | -75.5% | 0.09% | -67.5% |
Q4 2014 | $2,234,000 | – | 15,613 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |